Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 1, 2013, Pages 99-102

  Vena, Antonio ^a   Falcone, Marco ^a   Comandini, Emma ^b   Meledandri, Marcello ^b   Novelli, Andrea ^c   Campanile, Floriana ^d   Stefani, Stefania ^d   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Daptomycin; Linezolid resistant staphylococci; Meningitis; TMP SMX

Indexed keywords

C REACTIVE PROTEIN; CEFAZOLIN; COTRIFAMOLE; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABNORMAL LABORATORY RESULT; ADULT; ANASTOMOSIS; ANEURYSM CLIP; ARTICLE; BACTERIAL MENINGITIS; BRAIN ARTERY ANEURYSM; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; DRUG BLOOD LEVEL; FEMALE; FEVER; HUMAN; HYPOTENSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STAPHYLOCOCCUS EPIDERMIDIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BLOOD-BRAIN BARRIER; DAPTOMYCIN; FEMALE; GLYCOPEPTIDES; HUMANS; MENINGITIS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84876715968     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.01.021     Document Type: Article

References (36)

1. Bayston R. Hydrocephalus shunt infections. Antimicrob Chemother 1994, 34(Suppl. A):75-84.
2. Bolmström A. Determinations of minimum bactericidal concentrations, kill curves, and postantibiotic effects with the Etest technology. Diagn Microbiol Infect Dis 1994, 19:187-195.
3. Bongiorno D., Campanile F., Mongelli G., Baldi M.T., Provenzani R., Reali S., et al. DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy. J Antimicrob Chemother 2010, 65:2336-2340.
4. Campanile F., Bongiorno D., Borbone S., Falcone M., Giannella M., Venditti M., et al. In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes. Diagn Microbiol Infect Dis 2008, 61:227-231.
5. Cottagnoud P., Pfister M., Acosta F., Cottagnoud M., Flatz L., Kühn F., et al. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2004, 48:3928-3933.
6. Erritouni M., Ktaich N., Rahal J.J., Figueroa D., Nieto J., Urban C., et al. Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis. Case Report Med. 2012, 2012:593578.
7. Falcone M., Giannella M., Raponi G., Mancini C., Venditti M. Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?. Clin Microbiol Infect 2006, 12:96-97.
8. Falcone M., Campanile F., Giannella M., Borbone S., Stefani S., Venditti M. Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases. Diagn Microbiol Infect Dis 2007, 57:325-331.
9. Falcone M., Russo A., Pompeo M.E., Vena A., Marruncheddu L., Ciccaglioni A., et al. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy. Int J Antimicrob Agents 2012, 39:64-68.
10. Falcone M., Russo A., Cassetta M.I., Lappa A., Tritapepe L., Fallani S., et al. Daptomycin serum levels in critical patients undergoing continuous renal replacement. J Chemother 2012, 24:253-256.
11. Gerber P., Stucki A., Acosta F., Cottagnoud M., Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006, 57:720-723.
12. Gill C.J., Murphy M.A., Hamer D.H. Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect 2002, 45:129-132.
13. Hachem R., Afif C., Gokaslan Z., Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 2001, 20:432-434.
14. Jaspan H.B., Brothers A.W., Campbell A.J., McGuire J.K., Browd S.R., Manley T.J., et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010, 29:379-381.
15. Kelesidis T., Humphries R., Ward K., Lewinski M.A., Yang O.O. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis 2011, 286-290.
16. Kessler A.T., Kourtis A.P. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007, 35:271-274.
17. Krueger W.A., Kottler B., Will B.E., Heininger A., Guggenberger H., Unertl K.E. Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid. J Clin Microbiol 2004, 42:929-932.
18. Kruse A.J., Peerdeman S.M., Bet P.M., Debets-Ossenkopp Y.J. Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment. Eur J Clin Microbiol Infect Dis 2006, 25:135-137.
19. Kullar R., Chin J.N., Edwards D.J., Parker D., Coplin W.M., Rybak M.J. Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother 2010, 55:3505-3509.
20. Le J., Bookstaver P.B., Rudisill C.N., Hashem M.G., Iqbal R., James C.L., et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010, 44:2001-2006.
21. Lee D.H., Palermo B., Chowdhury M. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008, 47:588-590.
22. Lutsar I., McCracken G.H., Friedland I.R. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998, 27:1117-1127.
23. Mazzariol A., Lo Cascio G., Kocsis E., Maccacaro L., Fontana R., Cornaglia G. Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unit. Eur J Clin Microbiol Infect Dis 2012, 31:523-527.
24. Meka V.G., Pillai S.K., Sakoulas G., Wennersten C., Venkataraman L., DeGirolami P.C., et al. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 2004, 190:311-317.
25. Myrianthefs P., Markantonis S.L., Vlachos K., Anagnostaki M., Boutzouka E., Panidis D., et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006, 50:3971-3976.
26. Orsi G.B., Falcone M., Venditti M. Surveillance and management of multidrug-resistant microorganisms. Expert Rev Anti Infect Ther 2011, 9:653-679.
27. Peer M.A., Nasir R.A., Kakru D.K., Fomda B.A., Bashir G., Sheikh I.A. Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: first reports of linezolid resistance in coagulase negative staphylococci from India. Indian J Med Microbiol 2011, 29:60-62.
28. Riser M.S., Bland C.M., Rudisill C.N., Bookstaver P.B. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis. Ann Pharmacother 2010, 44:1832-1835.
29. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering R.C., Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004, 42:2398-2402.
30. Soriano A., Marco F., Martínez J.A., Pisos E., Almela M., Dimova V.P. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46:193-200.
31. Steed M.E., Vidaillac C., Rybak M.J. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob Agents Chemother 2010, 54:5187-5192.
32. Taglietti F., Campanile F., Capone A., Di Caro A., Grilli E., Stazi G., et al. Daptomycin efficacy in the central nervous system of a patient with disseminated methicillin-resistant Staphylococcus aureus infection: a case report. J Med Case Rep 2012, 6:264.
33. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
34. Van de Beek D., Drake J.M., Tunkel A.R. Nosocomial bacterial meningitis. N Engl J Med 2010, 362:146-154.
35. Villani P., Regazzi M.B., Marubbi F., Viale P., Pagani L., Cristini F., et al. Cerebrospinal fluid linezolid concentrations in post neurosurgical central nervous system infections. Antimicrob Agents Chemother 2002, 46:936-937.
36. Wahby K.A., Alangaden G.J. Daptomycin failure in a neutropenic leukemia patient with Staphylococcus aureus meningitis. Leuk Lymphoma 2012, 53:1610-1612.